(Q81390259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author

Rodrigo Corrêa-Oliveira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Bruno Mendes Roatt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Luiz Cosme Malaquias

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alexandre Barbosa Reis

12

Alexandre Barbosa Reis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

Andréa Teixeira de Carvalho

8 January 2020

4

Andréa Teixeira-Carvalho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

Rodrigo Dian de Oliveira Aguiar-Soares

8 January 2020

6

Rodrigo Dian de Oliveira Aguiar-Soares

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

Rodolfo Cordeiro Giunchetti

8 January 2020

1

Rodolfo Cordeiro Giunchetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

Olindo Assis Martins-Filho

8 January 2020

3

Olindo Assis Martins-Filho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Nádia das Dores Moreira

8

Nádia das Dores Moreira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Juliana Vitoriano de Souza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Luciana Lisboa Mota e Castro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Marta de Lana

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

24 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

7674-7686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17913311%20AND%20SRC:MED&resulttype=core&format=json

Leishmaniasis: current situation and new perspectives

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

[Control of canine visceral leishmaniasis: comparison of results from a rapid elimination program of serum-reactive dogs using an immunoenzyme assay and slower elimination of serum-reactive dogs using filter paper elution indirect immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Experimental models for leishmaniasis and for testing anti-leishmanial vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Vaccination against Leishmania infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Vaccines in leishmaniasis: advances in the last five years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Identification of Leishmania chagasi antigens recognized by human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Establishment of a microplate assay for flow cytometric assessment and it is use for the evaluation of age-related phenotypic changes in canine whole blood leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Chemotherapy of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

An experimental model for canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Immunology of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Adjuvant effects of saponins on animal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.009

Leishmaniasis vaccine candidates for development: a global overview

7 January 2021

1 reference

12 December 2020

Simple, rapid method for determining nitrates and nitrites in biological fluids

1 reference

12 December 2020

A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

1 reference

12 December 2020

Canine visceral leishmaniasis in northeast Brazil: assessment of serodiagnostic methods

1 reference

12 December 2020

Saponins as vaccine adjuvants

1 reference

12 December 2020

Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis

1 reference

12 December 2020

Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines

1 reference

12 December 2020

Control of zoonotic visceral leishmaniasis: is it time to change strategies?

1 reference

12 December 2020

Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes

1 reference

12 December 2020

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020